Thromboprophylaxis with enoxaparin versus unfractionated heparin in elderly patients with acute hip fracture: Survival at eight to ten years.

被引:0
|
作者
Borris, LC
Lassen, MR
Breindahl, M
Jensen, HP
机构
[1] Aarhus Univ Hosp, Dept Orthoped, DK-8000 Aarhus, Denmark
[2] Copenhagen Univ Hosp, Dept Orthoped, Hillerod, Denmark
[3] Aalborg Univ Hosp, Dept Orthoped, Aalborg, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2758
引用
收藏
页码:700A / 700A
页数:1
相关论文
共 38 条
  • [1] Assessment of HIT Antibody Complex in Hip Fracture Patients Receiving Enoxaparin or Unfractionated Heparin
    Griffin, Justin W.
    Hopkinson, William J.
    Lassen, Michael R.
    Thethi, Indermohan
    Litinas, Evangelos
    Fareed, Jawed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (06) : 567 - 571
  • [2] Differential Prevalence of Anti-Heparin-Platelet Factor 4 Antibodies In Elderly Patients with Acute Hip Fracture Undergoing Orthopaedic Surgery and Anticoagulated with Unfractionated Heparin and Enoxaparin
    Song, Christopher
    Cunanan, Josephine
    Kahn, Hussein
    Hoppensteadt, Debra
    Fareed, Jawed
    BLOOD, 2010, 116 (21) : 1714 - 1714
  • [3] Effectiveness and Safety of Enoxaparin Versus Unfractionated Heparin as Thromboprophylaxis in Hospitalized COVID-19 Patients: Real-World Evidence
    AlLehaibi, Lina H.
    Alomar, Mukhtar
    Almulhim, Abdulaziz
    Al-Makki, Sarah
    Alrwaili, Nazar R.
    Al-Bassam, Shahad
    Alsultan, Semat
    Al Saeed, Jenan
    Alsheef, Mohammad
    Abraham, Ivo
    Alamer, Ahmad
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (04) : 361 - 374
  • [4] The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients
    Pineo, Graham F.
    Lin, Jay
    Annemans, Lieven
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2012, 4 : 99 - 107
  • [5] Biomarker profiling in elderly patients with acute hip fracture: modulation by prophylactic dosage of enoxaparin
    Knesek, Michael
    Litinas, Evangelos
    Lasssen, Michael
    Borris, Lars
    Hopkinson, William
    Hoppensteadt, Debra
    Fareed, Jawed
    FASEB JOURNAL, 2009, 23
  • [6] Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in patients ≥15 years compared with <75 years
    White, Harvey D.
    Shui, Amy
    Jacob, Ashok J.
    Gotcheva, Nina
    Polonetsky, Leonid
    Antman, Elliott M.
    Braunwald, Eugene B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 249A - 249A
  • [7] Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL Trial
    Liu, Zhenyu
    Silvain, Johanne
    Kerneis, Mathieu
    Barthelemy, Olivier
    Payot, Laurent
    Choussat, Remi, Jr.
    Sabouret, Pierre
    Cohen, Marc
    Pollack, Charles V., Jr.
    Goldstein, Patrick
    Zeymer, Uwe
    Huber, Kurt
    Vicaut, Eric
    Collet, Jean-Philippe
    Montalescot, Gilles
    ANGIOLOGY, 2017, 68 (01) : 29 - 39
  • [8] Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial
    Lopes, Renato D.
    Alexander, Karen P.
    Marcucci, Gretchen
    White, Harvey D.
    Spinler, Sarah
    Col, Jacques
    Aylward, Philip E.
    Califf, Robert M.
    Mahaffey, Kenneth W.
    EUROPEAN HEART JOURNAL, 2008, 29 (15) : 1827 - 1833
  • [9] LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN) VERSUS STANDARD HEPARIN IN THE PREVENTION OF VENOUS THROMBOEMBOLISM IN OPERATIVELY TREATED HIP FRACTURE PATIENTS
    BORRIS, LC
    LASSEN, MR
    ANDERSEN, BS
    POULSEN, CA
    HANSEN, BR
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1118 - 1118
  • [10] Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in Patients with Acute Coronary Syndrome in PolandModelling Study from the Hospital Perspective
    Ewa Orlewska
    Andrzej Budaj
    Dariusz Tereszkowski-Kaminski
    PharmacoEconomics, 2003, 21 : 737 - 748